000 | 01601 a2200457 4500 | ||
---|---|---|---|
005 | 20250513212504.0 | ||
264 | 0 | _c20000718 | |
008 | 200007s 0 0 eng d | ||
022 | _a0306-5251 | ||
024 | 7 |
_a10.1046/j.1365-2125.2000.00197.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSomer, M | |
245 | 0 | 0 |
_aInfluence of hydroxychloroquine on the bioavailability of oral metoprolol. _h[electronic resource] |
260 |
_bBritish journal of clinical pharmacology _cJun 2000 |
||
300 |
_a549-54 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacokinetics |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntimalarials _xpharmacology |
650 | 0 | 4 |
_aAntirheumatic Agents _xpharmacology |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aCytochrome P-450 CYP2D6 Inhibitors |
650 | 0 | 4 |
_aDextromethorphan _xurine |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxychloroquine _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetoprolol _xpharmacokinetics |
700 | 1 | _aKallio, J | |
700 | 1 | _aPesonen, U | |
700 | 1 | _aPyykkö, K | |
700 | 1 | _aHuupponen, R | |
700 | 1 | _aScheinin, M | |
773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 49 _gno. 6 _gp. 549-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2125.2000.00197.x _zAvailable from publisher's website |
999 |
_c10799845 _d10799845 |